CIPLA
Back to All Ratios
|
CIPLA Last 5 Year EBIT Margin History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EBIT Margin(%) | 16.35 | 13.41 | 12.11 | 12.22 | 8.76 |
What is the latest EBIT Margin ratio of CIPLA ?
Year | EBIT Margin |
---|---|
Mar2024 | 16.35 |
Mar2023 | 13.41 |
Mar2022 | 12.11 |
Mar2021 | 12.22 |
Mar2020 | 8.76 |
How is EBIT Margin of CIPLA Trending?
Years | EBIT Margin | % Change | |
---|---|---|---|
Mar2024 | 16.35 | 21.92 | |
Mar2023 | 13.41 | 10.73 | |
Mar2022 | 12.11 | -0.90 | |
Mar2021 | 12.22 | 39.50 | |
Mar2020 | 8.76 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,591.2 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics | |
MANKIND PHARMA | ₹98,309.9 Cr | 1.1% | -7% | 9.7% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -0.1% |
0.2% |
-2.1% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses